Patients who achieved long-term clinical complete response and subsequently terminated multidisciplinary and anti-HER2 therapy for metastatic breast cancer: A case series

about

Patients who achieved long-term clinical complete response and subsequently terminated multidisciplinary and anti-HER2 therapy for metastatic breast cancer: A case series

Item

http://www.wikidata.org/entity/Q57815432

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Patients who achieved long-ter ...... c breast cancer: A case series

@en

Patients who achieved long-ter ...... c breast cancer: A case series

@nl

type

Item

label

Patients who achieved long-ter ...... c breast cancer: A case series

@en

Patients who achieved long-ter ...... c breast cancer: A case series

@nl

prefLabel

Patients who achieved long-ter ...... c breast cancer: A case series

@en

Patients who achieved long-ter ...... c breast cancer: A case series

@nl

P1476

Patients who achieved long-ter ...... c breast cancer: A case series

@en

P2093

Fumiaki Yotsumoto

http://www.w3.org/2001/XMLSchema#string

Haruko Takuwa

http://www.w3.org/2001/XMLSchema#string

Wakako Tsuji

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab-containing regimens for metastatic breast cancer

Duration of trastuzumab in patients with HER2-positive metastatic breast cancer in prolonged remission

Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Sustained complete remission of human epidermal growth factor receptor 2-positive metastatic breast cancer in the liver during long-term trastuzumab (Herceptin) maintenance therapy in a woman: a case report.

P304

125-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJSCR.2018.10.008

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30343261

http://www.w3.org/2001/XMLSchema#string

P932

6198101

http://www.w3.org/2001/XMLSchema#string